drugset / Trial / NCT00406432

A Repeat Dose Pharmacokinetic Study Of Paroxetine CR Tablet In Healthy Chinese Subjects

NCT00406432

Phase 1 Completed 12 enrolled GlaxoSmithKline
RandomizedSingle-groupOpen-labelTreatment

Summary

The study was designed to assess the steady-state pharmacokinetic profile of paroxetine after 14 day repeated daily dosing of the controlled release tablet formulation (25 mg) in healthy Chinese subjects.

Timeline

Start
2006-05-09
Primary completion
2006-06-02
Completion
2006-06-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Paroxetine Small molecule 25 mg

Indications